Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study

Objective Neoadjuvant chemoradiation (CRT) using paclitaxel and carboplatin has significantly improved the survival rates in carcinoma esophagus, especially in squamous cell carcinoma (SCC). This regimen has not been adequately explored prospectively as a definitive CRT strategy. Our aim was to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Deepa M., Malik, Monica Irukulla, Jonnadula, Jyothi, Ahmed, Fayaz, Valiyaveettil, Deepthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687861/
https://www.ncbi.nlm.nih.gov/pubmed/34938676
http://dx.doi.org/10.1055/s-0041-1727067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687861/
https://www.ncbi.nlm.nih.gov/pubmed/34938676
http://dx.doi.org/10.1055/s-0041-1727067

Ejemplares similares